Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 14:2022:5817841.
doi: 10.1155/2022/5817841. eCollection 2022.

Association of XRCC3, XRCC4, BAX, and BCL-2 Polymorphisms with the Risk of Breast Cancer

Emre Ozoran  1 , Fadime Didem Can Trabulus  2 , Duygu Erhan  3 , Bahadir Batar  4 , Mehmet Guven  3
Affiliations

Association of XRCC3, XRCC4, BAX, and BCL-2 Polymorphisms with the Risk of Breast Cancer

Emre Ozoran et al. Int J Breast Cancer. .

Abstract

Background: Breast cancer is the most common malignancy in women. Genetic risk factors associated with breast cancer incidence have been identified.

Aims: This study is aimed at determining the association of XRCC3 Thr241Met (rs861539), XRCC4 G(-1394) T (rs6869366) DNA repair and BAX G(-248) A (rs4645878), and BCL2 C(-938) A (rs2279115) apoptotic gene polymorphisms with breast cancer.

Materials and methods: Genetic analysis was performed using peripheral blood samples. Gene polymorphisms were detected by using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique. 175 patients and 158 healthy controls were enrolled in the study.

Results: Breast cancer risk was 5.43 times more in individuals with AA genotype of Bax G(-248) A (rs4645878) (P = 0.002). The risk of metastasis was 11 times with this genotype. It was associated with 6 times more risk of having a tumor larger than 2 cm. The risk of breast cancer was 2.77 times more in individuals carrying the Met/Met genotype of XRCC3 Thr241Met (rs861539) (P = 0.009). The risk of having advanced clinical stage (stage III+IV) with the Met/Met genotype was 4 times more increased. No relationship with breast cancer was found with XRCC4 G(-1394) T (rs6869366) and BCL2 C(-938) A (rs2279115) gene polymorphisms.

Conclusion: Multicenter trials using subjects with genetic variations are needed to establish the relationship between breast cancer and single gene polymorphism.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Similar articles

See all similar articles

Cited by

References

    1. Gochhait S., Bukhari S. I. A., Bairwa N., et al. Implication of BRCA2 -26G>A 5' untranslated region polymorphism in susceptibility to sporadic breast cancer and its modulation by p53codon 72 Arg>pro polymorphism. Breast Cancer Research . 2007;9(5):p. R71. doi: 10.1186/bcr1780. - DOI - PMC - PubMed
    1. Tang D. G., Porter A. T. Target to apoptosis: a hopeful weapon for prostate cancer. Prostate . 1997;32(4):284–293. doi: 10.1002/(SICI)1097-0045(19970901)32:4<284::AID-PROS9>3.0.CO;2-J. - DOI - PubMed
    1. Brown L. F., Berse B., Jackman R. W., et al. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Human Pathology . 1995;26(1):86–91. doi: 10.1016/0046-8177(95)90119-1. - DOI - PubMed
    1. Gasparini G., Bonoldi E., Gatti C., et al. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma. Journal of the National Cancer Institute . 1997;89(2):139–147. doi: 10.1093/jnci/89.2.139. - DOI - PubMed
    1. Thacker J. The _RAD51_ gene family, genetic instability and cancer. Cancer Letters . 2005;219(2):125–135. doi: 10.1016/j.canlet.2004.08.018. - DOI - PubMed